by Lia Eustachewich
Johnson & Johnson said Friday its COVID-19 vaccine is close to 66 percent effective overall — short of the other two approved inoculations currently on the market in the US.
The efficacy of the New Jersey-headquartered medical giant’s vaccine also varies by location — but was found to be 85 percent effective in preventing severe cases leading to hospitalization or death, medical publication Stat News reported.
“In a pandemic, if you can, with a single-dose vaccine, very quickly eliminate the severe consequences of death, hospitalization, and severe disease, that’s what’s important for society,” Paul Stoffels, Johnson & Johnson’s chief scientific officer, told Stat News. Read the rest at nypost.com.